About Us Resources Catalysts Start Free Trial →

Loading…

Day Trader Sniper provides algorithmic alerts and analysis, not trade advice.
Not financial advice. Trade at your own risk.

Quick Links

Download The App Resources Market Feed Stocks

Catalysts About Us Support Privacy policy Terms of use

©2026 Day Trader Sniper - all rights reserved

Home›Catalysts›Regulatory and Clinical

Catalyst Category

Regulatory and Clinical

Live feed of every catalyst classified under Regulatory and Clinical.

CATALYSTS IN FEED

168

AVG MAX MOVE

+116.8%

POSITIVE MOVES

100%

LARGEST MOVE

+664.1%

DSMB Efficacy Met FDA 510(k) Cleared FDA Approval FDA Fast Track FDA Meeting FDA Meeting Granted Generic Drug Approved Inconclusive Topline Results IND Cleared for Study IND Filed NDA Resubmission Orphan Drug Designation Positive Subgroup Data Positive Topline Results Primary Endpoint Met SPA Agreement Study Complete Trial Enrollment Complete

Range–

Showing 7 of 168

Regulatory and ClinicalOct 6, 2025 · 3:59pm ET

COCHEnvoy Medical, Inc. Class A Common Stock

Envoy Medical Receives FDA Approval for Final Trial Stage of Cochlear Implant

The company is now set to proceed with the next phase of its clinical trials.

Be first on the next Regulatory and Clinical catalyst.

Day Trader Sniper alerts you the instant a setup like this triggers.

Download Free →

Max move

+226.5%

RVOL

13.7x

Max high

$2.71

Fuel

20m

Regulatory and ClinicalOct 6, 2025 · 3:59pm ET

COCHEnvoy Medical, Inc. Class A Common Stock+226.5%

Envoy Medical Receives FDA Approval for Final Trial Stage of Cochlear Implant

RVOL

13.7x

Max high

$2.71

Fuel

20m

Regulatory and ClinicalOct 2, 2025 · 7:25pm ET

ANROAlto Neuroscience, Inc.

Alto Neuroscience Investigated for Alleged Misleading Statements

Johnson Fistel, PLLP announced the investigation on October 3, 2025.

Regulatory and ClinicalOct 2, 2025 · 7:25pm ET

ANROAlto Neuroscience, Inc.+88.1%

Alto Neuroscience Investigated for Alleged Misleading Statements

Regulatory and ClinicalSep 29, 2025 · 4:00am ET

ENTAENANTA PHARMACEUTICALS INC

Enanta Pharmaceuticals Inc. Reported Topline Data from Phase 2b Study of Zelicapavir

The study evaluated the efficacy and safety of Zelicapavir, an RSV pill.

Regulatory and ClinicalSep 29, 2025 · 4:00am ET

ENTAENANTA PHARMACEUTICALS INC+65.2%

Enanta Pharmaceuticals Inc. Reported Topline Data from Phase 2b Study of Zelicapavir

Regulatory and ClinicalSep 22, 2025 · 7:59pm ET

SSKNSTRATA SKIN SCIENCES INC

STRATA Skin Sciences Demonstrates Superior Safety and Unprecedented Response Rates in Vitiligo Combination Therapy

Peer-reviewed publication highlights new treatment approach.

Regulatory and ClinicalSep 22, 2025 · 7:59pm ET

SSKNSTRATA SKIN SCIENCES INC+147.9%

STRATA Skin Sciences Demonstrates Superior Safety and Unprecedented Response Rates in Vitiligo Combination Therapy

Regulatory and ClinicalSep 17, 2025 · 6:44pm ET

ADGMAdagio Medical Holdings, Inc Common Stock

Adagio Medical Announces FULCRUM-VT Study Results Presentation

Results to be presented at the 0th Annual International Symposium on Ventricular Arrhythmias.

Regulatory and ClinicalSep 17, 2025 · 6:44pm ET

ADGMAdagio Medical Holdings, Inc Common Stock+72.4%

Adagio Medical Announces FULCRUM-VT Study Results Presentation

Regulatory and ClinicalSep 16, 2025 · 7:40pm ET

HINDVyome Holdings, Inc

Vyome Holdings Unveils Preclinical Data for VT-1908 Eye Drops to Treat Uveitis

The company announced the data on a leading cause of blindness.

Regulatory and ClinicalSep 16, 2025 · 7:40pm ET

HINDVyome Holdings, Inc+205.7%

Vyome Holdings Unveils Preclinical Data for VT-1908 Eye Drops to Treat Uveitis

Regulatory and ClinicalSep 15, 2025 · 7:53pm ET

APVOAptevo Therapeutics Inc

Aptevo Therapeutics' Mipletamig Achieves 100% Remission in AML Trial Cohort

Mipletamig demonstrated complete remission in a Phase 1b/2 trial.

Regulatory and ClinicalSep 15, 2025 · 7:53pm ET

APVOAptevo Therapeutics Inc+135.4%

Aptevo Therapeutics' Mipletamig Achieves 100% Remission in AML Trial Cohort

1
…
13
14
15
…
24

RVOL

13.6x

Max high

$8.46

Fuel

7h 32m

RVOL

10.6x

Max high

$15.88

Fuel

10h 13m

RVOL

9.5x

Max high

$4.19

Fuel

1h 39m

RVOL

11.8x

Max high

$2.50

Fuel

8m

RVOL

11.4x

Max high

$18.34

Fuel

7m

RVOL

3.4x

Max high

$61.02

Fuel

14m